|
Prospective Evaluation of Breast-Conserving Surgery Alone in Low-Risk Ductal Carcinoma in Situ (DCIS)
RECRUITINGSponsored by Ontario Clinical Oncology Group (OCOG)
Actively Recruiting
SponsorOntario Clinical Oncology Group (OCOG)
Started2022-11-23
Est. completion2030-11-30
Eligibility
Age46 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04797299
Summary
To evaluate whether the combination of clinicopathological factors and the use of the Oncotype DX DCIS score can avoid radiation in women with low risk DCIS who have had breast conserving surgery (BCS)
Eligibility
Age: 46 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria: 1. Female patient \> 45 years of age with DCIS without microinvasion. 2. Tumour size ≤ 2.5cm. 3. Treated by BCS with clear resection margins ≥ 2 mm or no residual disease on re-excision.\* \* Patients with anterior margins and posterior margins ≥1 mm are eligible. Or if the dissection was confirmed to be taken to skin and down to fascia with no DCIS present at inked margins. 4. Oncotype DX DCIS score with a predicted 10-year risk of LR ≤10%. Exclusion Criteria: 1. Multifocal DCIS. 2. History of any invasive breast cancer or non-invasive breast cancer in the ipsilateral breast. 3. Synchronous or previous invasive or non-invasive breast cancer. 4. Prior history of invasive cancer within the last 5 years, excluding non-melanoma skin cancers. 5. ECOG performance status ≥3. 6. Life expectancy \<10 years. 7. Geographic inaccessibility for follow-up.
Conditions3
Breast CancerCancerDCIS
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
SponsorOntario Clinical Oncology Group (OCOG)
Started2022-11-23
Est. completion2030-11-30
Eligibility
Age46 Years+
SexFEMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT04797299